Auxilium Pharmaceuticals announces FDA approval for Peyronie's disease drug - Pharmaceutical Business Review

09-12-2013 Pharmaceutical Business ReviewComments (0)

Auxilium PharmaceuticalsPharmaceuticalXiaflex

Auxilium Pharmaceuticals, a biopharmaceutical company, has obtained an approval from the US Food and Drug Administration (FDA) for Xiaflex (collagenase clostridium histolyticum) for the treatment of Peyronie's disease. The company claims that Xiaflex ...

Read more on Pharmaceutical Business Review

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top